- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04532437
Computer-based Skin Aging Simulation for Skin Cancer Prevention
December 14, 2021 updated by: University Hospital, Basel, Switzerland
Computer-based Skin Aging Simulation for Skin Cancer Prevention: A Pilot Study
This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.
Study Overview
Status
Completed
Conditions
Detailed Description
In young adulthood an increasing UV-exposure often starts because of the belief that tanning increases attractiveness].
Raising awareness and educating students and adults regarding practices for skin cancer prevention are critical since skin cancer is increasing rapidly worldwide.
Skin cancer preventive interventions for adolescents are needed to improve their motivation for sun safety behavior.
This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Basel, Switzerland, 4031
- Department of Dermatology, University Hospital Basel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Young healthy female volunteers aged 18-35 years, e.g.
medical students of the University Basel, who do not have any skin diseases requiring medical therapy
Description
Inclusion Criteria:
- healthy female volunteers
- written,Institutional Review Board (IRB)/ Independent Ethics Committee (IEC)-approved informed consent.
Exclusion Criteria:
- skin diseases requiring medical therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in visual analogue scale (VAS) score regarding importance of UV- protection
Time Frame: before and after the skin aging simulation (each scoring session will take about 15-20 minutes)
|
Change in VAS score regarding importance of UV- protection (0 = not important; 10 = extremly important)
|
before and after the skin aging simulation (each scoring session will take about 15-20 minutes)
|
Change in VAS score regarding rating of personal exposure to UV radiation
Time Frame: before and after the skin aging simulation (each scoring session will take about 15-20 minutes)
|
Change in VAS score regarding rating of personal exposure to UV radiation (0 = no exposure; 10 = very high exposure)
|
before and after the skin aging simulation (each scoring session will take about 15-20 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Questionnaire asking for reduction of UV- exposure (yes/no)
Time Frame: after the skin aging simulation (each scoring session will take about 15-20 minutes)
|
Questionnaire asking for reduction of UV- exposure (yes/no)
|
after the skin aging simulation (each scoring session will take about 15-20 minutes)
|
Questionnaire asking for intensification of UV protection measures (yes/ no)
Time Frame: after the skin aging simulation (each scoring session will take about 15-20 minutes)
|
Questionnaire asking for intensification of UV protection measures (yes/ no)
|
after the skin aging simulation (each scoring session will take about 15-20 minutes)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 9, 2021
Primary Completion (ACTUAL)
March 19, 2021
Study Completion (ACTUAL)
March 19, 2021
Study Registration Dates
First Submitted
August 25, 2020
First Submitted That Met QC Criteria
August 25, 2020
First Posted (ACTUAL)
August 31, 2020
Study Record Updates
Last Update Posted (ACTUAL)
December 15, 2021
Last Update Submitted That Met QC Criteria
December 14, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Req-2020-00963; sp20Maul3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Aging
-
Amazentis SAproDERM GmbHCompleted
-
Endymion Medical LtdCompleted
-
Endymion Medical LtdCompletedSkin Aging | Skin WrinklingIsrael
-
BioibericaRecruiting
-
Crown Laboratories, Inc.Completed
-
HugelCompletedSkin AgingKorea, Republic of
-
Technological Centre of Nutrition and Health, SpainUniversity Rovira i Virgili; Hospital Universitari Sant Joan de Reus; Fundació... and other collaboratorsCompleted
-
Medy-ToxCompletedSkin AgingKorea, Republic of
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Revance Therapeutics, Inc.Completed
Clinical Trials on artificial intelligence-based skin aging simulation
-
Cairo UniversityNot yet recruitingOral Cancer | Leukoplakia | Oral Lichen Planus | Erythroplakia | Fordyce Granule | Leukoedemas, Oral | Lichenoid Reaction
-
Melanoma and Skin Cancer Trials LimitedMonash UniversityCompletedSkin Cancer | Melanoma (Skin)Australia
-
Technische Universität DresdenRecruitingInvasive Mechanical VentilationSwitzerland, Germany, Spain, United States, Serbia
-
Fundacao ChampalimaudEuropean Commission; Cankado GmbH; Bocconi University; INESC TEC - Institute for... and other collaboratorsRecruitingBreast CancerGermany, Israel, Italy, Portugal, Poland
-
Izmir Tinaztepe UniversityCompleted
-
Cairo UniversityRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingProstatic Neoplasms | Lymphatic MetastasisChina
-
Hasanuddin UniversityChulalongkorn UniversityRecruitingOvarian Cancer | Endometrial Hyperplasia | Endometrial CancerIndonesia
-
University College, LondonM.D. Anderson Cancer Center; National Cancer Institute (NCI); National Institutes... and other collaboratorsNot yet recruitingCancer Head Neck | Cancer of Prostate | Cancer Cervix
-
Yonsei UniversityRecruitingAtrial FibrillationKorea, Republic of